Growth Metrics

Rockwell Medical (RMTI) Cash from Investing Activities (2016 - 2025)

Rockwell Medical's Cash from Investing Activities history spans 16 years, with the latest figure at -$4.1 million for Q4 2025.

  • For Q4 2025, Cash from Investing Activities fell 1144.28% year-over-year to -$4.1 million; the TTM value through Dec 2025 reached -$8.5 million, down 75.59%, while the annual FY2025 figure was -$8.5 million, 75.59% down from the prior year.
  • Cash from Investing Activities reached -$4.1 million in Q4 2025 per RMTI's latest filing, up from -$4.3 million in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of $9.1 million in Q1 2022 to a low of -$14.7 million in Q3 2022.
  • Average Cash from Investing Activities over 5 years is -$927000.0, with a median of -$83500.0 recorded in 2023.
  • Peak YoY movement for Cash from Investing Activities: skyrocketed 2782.81% in 2024, then tumbled 1144.28% in 2025.
  • A 5-year view of Cash from Investing Activities shows it stood at $540000.0 in 2021, then soared by 495.93% to $3.2 million in 2022, then plummeted by 37.6% to $2.0 million in 2023, then tumbled by 116.53% to -$332000.0 in 2024, then crashed by 1144.28% to -$4.1 million in 2025.
  • Per Business Quant, the three most recent readings for RMTI's Cash from Investing Activities are -$4.1 million (Q4 2025), -$4.3 million (Q3 2025), and -$103000.0 (Q2 2025).